Posters and Presentations

1. Tave A, Pezzullo JC, Kardia S, Li J, Jones JK. Methodological Challenges in Evaluating Long-Term Safety of Quinacrine Non-Surgical Sterilization. Presented at 6th Asian Conference on Pharmacoepidemiology in Beijing, China, October 28-30, 2011. [ PDF ]

2. Kapasi A, Kamani S, Nguyen BA, Goehring EL Jr, Singh VP, Jones JK. An Analysis of Registries with Birth Defect Data Using an Online Database Resource. Pharmacoepidemiol Drug Safe. 2011;20(S1):S52. [ PDF ]

3. Bao-Anh Nguyen-Khoa, Earl Goehring Jr., Kim Alexander, Wei Dong, Pavel Napalkov, and Judith K. Jones. Serious Infections in Rheumatoid Arthritis Patients Switching Anti-Tumor Necrosis Factor Drugs. Presented at 74th Annual Meeting of the American College of Rheumatology, Atlanta, GA. November 6-11, 2010. [ PDF ]

4. Kapasi AJ, Nguyen-Khoa BA, Goehring Jr EL, Alexander K, Napalkov PK, Foskett N, Jones JK. Accuracy of Reporting and Method for Classifying Progressive Multifocal Leukoencephalopathy (PML) within the FDA Adverse Event Reporting System (AERS). Pharmacoepidemiol Drug Safe. 2010;19(S1):S46. [ PDF ]

5. Kamani S, Goehring Jr EL, Kapasi AJ, Nguyen-Khoa BA, Singh VP, Jones JK. Educating a pharmacoepidemiology researcher on selecting optimal healthcare databases for research. Pharmacoepidemiol Drug Safe. 2010;19(S1):S87. [ PDF ]

6. Daniel GW, Eisenberg DF, Jones JK, Goehring EL, Winters P, Levin J, Wahl PM, Bohn RL. Validation of a Claims-Based Diagnostic Code for Stevens-Johnson Syndrome (SJS) in a Commercially-Insured Population. Pharmacoepidemiol Drug Safe. 2010;19(S1):S195. [ PDF ]

7. Li J, Jones JK, Tave A, Pezzullo JC. Methodological Challenges in Evaluating Long-Term Safety of Quinacrine Non-Surgical Sterilization. Pharmacoepidemiol Drug Safe. 2010;19(S1):S299. [ PDF ]

8. Kamani SA, Goehring Jr EL, Singh VP, Nguyen-Khoa BA, Kapasi AJ, Jones JK. Rationale and Development of an Online Directory of Database Profiles for Pharmacoepidemiology, Outcomes and Population Research. Value Health 2010;13:A15. [ PDF ]

9. Goehring Jr EL, Nguyen-Khoa BA, Werther W, Jones JK. Validation of Diabetic Macular Edema (DME) through Claims Profile Review. Pharmacoepidemiol Drug Safe. 2009;18(S1):S50. [ PDF ]

10. Nguyen-Khoa BA, Goehring Jr EL, Werther W, Jones, JK. Myocardial Infarction and Cerebrovascular Accident in Patients with Diabetic Macular Edema. Pharmacoepidemiol Drug Safe. 2009;18(S1):S52. [ PDF ]

11. Marfatia A, Maneno M, Li J, Jones JK. Longitudinal Assessment of Smoking in the Health Improvement Network (THIN) Database. Pharmacoepidemiol Drug Safe. 2009;18(S1):S52. [ PDF ]

12. Nguyen-Khoa BA, Goehring Jr EL, Alexander K, Napalkov PK, Seitzman RL, Jones, JK. Descriptive Analysis of Progressive Multifocal Leukoencephalopathy (PML) within the FDA Adverse Event Reporting System. Pharmacoepidemiol Drug Safe. 2009;18(S1):S252. [ PDF ]

13. Fung AE, Apte RS, Nguyen-Khoa BA, Goehring Jr EL, Werther W, Jones JK. Myocardial Infarction and Cerebrovascular Accidents in Patients with Diabetic Macular Edema. 2009 ARVO Annual Meeting, May 3-7, 2009, Fort Lauderdale, FL. [ PDF ]

14. Manack A, Motsko SP, Jones JK, Ravelo A, Haag-Molkenteller C, Dmochowski R. Epidemiology of Neurogenic Bladder Patients in a US Claims Database. American Urology Association Annual Meeting, April 25-30, 2009, Chicago, IL. (Moderated Poster Presentation.) [ PDF ]

15. Manack A, Motsko SP, Jones JK, Ravelo A, Haag-Molkenteller C, Dmochowski R. Medication and Healthcare Utilization of Neurogenic Bladder Patients in a US Claims Database. American Urology Association Annual Meeting, April 25-30, 2009, Chicago, IL. (Moderated Poster Presentation.) [ PDF ]

16. Laudati JT, Motsko SP, Jones JK. Risk of Chronic End Stage Renal Disease After Use of ACE Inhibitors Compared to Other Antihypertensives or No Antihypertensive Use in a Cohort of Diabetic Patients in the United Kingdom. Pharmacoepidemiol Drug Safe. 2008;17:S233. [ PDF ]

17. Li J, Motsko SP, Goehring Jr EL, Jones JK. Prevalence of Dyslipidemia and Its Risk Factors in US Children. Pharmacoepidemiol Drug Safe. 2008;17:S253. [ PDF ]

18. Motsko SP, Wallace AE, Pollack M, Goehring Jr EL, Bohn RL, Jones JK. Analysis of a Marker for Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis among 167 Million Insured US Patients. Pharmacoepidemiol Drug Safe. 2008;17:S255. [ PDF ]

19. Russmann S, Lamerato L, Motsko SP, Pezzullo JC, Faber MD, Jones JK. In Patients With Preexisting Renal Dysfunction Oral Sodium Phosphate (Phospho-Soda®) Is Associated With Creatinine Increase Compared To Polyethylenglycol (Colyte®). Pharmacoepidemiol Drug Safe. 2008;17:S150. [ PDF ]

20. Motsko SP, Nguyen-Khoa BA, Napalkov P, Dong W, Vendiola RM, Goehring EL Jr, Jones JK. Serious Cardiovascular Disease and Infections in Patients with Systemic Lupus Erythematosus in a Large US Managed Care Plan Stratified by Therapeutic Intensity. Arthritis and Rheumatism 2007;56(9):S71. [ PDF ]

21. Do DV, Nguyen-Khoa BA, Goehring EL Jr, Werther W, Gower EW, Nguyen QD, Jones JK. Risk of Myocardial Infarction and Cerebrovascular Accident in Neovascular Age-Related Macular Degeneration Patients and Controls. Program and Abstracts of the 40th Annual Scientific Meeting of the Retina Society; September 27-30, 2007; Boston, Massachusetts (Podium Presentation).

22. Stephen P Motsko, PharmD, PhD and Judith K Jones, MD, PhD. A Study of the Association between Alzheimer's Disease and Fractures in an Elderly Population. American College of Epidemiology's 25th Annual Meeting, Ft. Lauderdale, Florida. September 15-18, 2007. [ PDF ]

23. Motsko SP, Nguyen-Khoa B, Napalkov P, Dong W, Vendiola RM, Goehring Jr EL, Jones JK. Select Medical Events in Lupus Patients Stratified by Therapeutic Intensity. Pharmacoepidemiol Drug Safe. 2007;16:S176. [ PDF ]

24. Motsko SP, Russmann S, Ming EE, Singh VP, Vendiola RM, Jones JK. Effectiveness of Rosuvastatin Compared to Other Statins for the Prevention of Fatal and Non-fatal Cardiovascular Events in Clinical Practice - An Epidemiological Study. Value in Health 2007 10(6):A406. [ PDF ]

25. Jones JK, Goehring Jr EL, Nguyen B, Vendiola RM, Napalkov P, Dong W. Sjogren’s Syndrome within a Large US Managed Care Population. ACR-ARHP Annual Scientific Meeting Washington, DC, November 10-15, 2006. (Poster Presentation.) [ PDF ]

26. Motsko SP, Corrao MA, Vendiola RM, Davis KJ, Goehring EL, Jones JK. Risk of systemic adverse effects and nasal perforation with fluticasone propionate as compared to other inhaled nasal steroids. Pharmacoepidemiol Drug Safe. 2006;15:S200. [ PDF ]

27. Goehring EL, Nguyen B, Werther W, Napalkov P, Jones JK. Incidence of myocardial infarction and cerebrovascular accidents in patients with wet age-related macular degeneration in a commercially insured population. Pharmacoepidemiol Drug Safe. 2006;15:S270. [ PDF ]

28. Motsko SP, Jones JK. A study of the association between hypothyroidism and open-angle glaucoma in an elderly population. Pharmacoepidemiol Drug Safe. 2006;15:S271. [ PDF ]

29. Nguyen B, Goehring EL, Werther W, Napalkov P, Jones JK. Macular degeneration and mortality in NHANES III participants. Pharmacoepidemiol Drug Safe. 2006;15:S277. [ PDF ]

30. Curkendall SM, Lanes S, de Luise C, Stang MR, Goehring EL, She D, Jones JK. A method of assigning severity of chronic obstructive pulmonary disease using administrative claims. Pharmacoepidemiol Drug Safe. 2005;14:S113. [ PDF ]

31. Goehring EL, Nguyen B, Vendiola RM, Napalkov P, Dong W, Jones JK. Period prevalence of four autoimmune diseases within a large US managed care organization. Pharmacoepidemiol Drug Safe. 2005;14:S147. [ PDF ]

32. Pezzullo JC, Marfatia AA, Nguyen B, Goehring EL, Jones JK. Simulation of a proposed trial to evaluate the cost-effectiveness of using a combination regimen for the treatment of acute sinusitis. Value Health 2005;8:243-244. [ PDF ]

33. Curkendall SM, Stang MR, Jones JK, Barbey JT, Goehring EL, Lanes S, de Luise C. Accuracy of inpatient cardiovascular diagnoses in a Saskatchewan Health Database. Pharmacoepidemiol Drug Safe. 2004;13:S44.

34. Curkendall SM, Goehring EL, Stang MR, de Luise C, Lanes S, Jones JK. Smoking behavior among COPD patients, Saskatchewan, Canada. Value Health 2004;7:256.

35. Curkendall SM, de Luise C, Lanes S, Jones JK, Goehring EL, She D. Cardiovascular Morbidity and Mortality Among Persons With Chronic Obstructive Pulmonary Disease. 100th International Conference of American Thoracic Society, Orlando, FL, USA. May 21-26, 2004. (Poster Presentation).

36. Curkendall SM, Mo J, Jones JK, Goehring EL. Increased in-hospital mortality and comorbidities in patients treated with systemic antifungal medications. Pharmacoepidemiol Drug Safe. 2003;12:S107.

37. Curkendall SM, Goehring EL, She D, Pezzullo JC, Jones JK. Comparison of treatment cost for depression between fluoxetine, paroxetine, sertraline, and venlafaxine Using Managed Care Claims Data. Value Health 2002;5:119.

38. Curkendall SM, Jones JK, Dieck G, Goehring EL, She D, Mo J. Fluoroquinolones and risk of liver Injuries: Comparison of trovafloxacin, ciprofloxacin and levofloxacin. Pharmacoepidemiol Drug Safe. 2001;10:S69.

39. Jones JK, Guo J, Fife D, Shannon M, Curkendall SM, Goehring EL. Pharmacies as potential intervention points: cisapride and contraindicated drugs. Pharmacoepidemiol Drug Safe. 2000;9:S1.

40. Curkendall SM, Jones JK, Goehring EL. New Claims for Medically Detected Erectile Dysfunction and Related Diseases Before and After Viagra® (sildenafil citrate). European Association of Urologists, Brussels, Belgium. April 12-14, 2000. (Poster Presentation).